ImmunityBio, Inc. (IBRX)

ImmunityBio Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for ImmunityBio stock have an average target of 17.38, with a low estimate of 4.75 and a high estimate of 30. The average target predicts an increase of 563.36% from the current stock price of 2.62.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$4.75	$17.38	$30	$30
Change	+81.30%	+563.36%	+1045.0%	+1045.0%

Analyst Ratings

The average analyst rating for ImmunityBio stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24	Dec '24
Strong Buy	0	0	0	1	1	1
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $30	Strong Buy	Maintains	$30	+1,045.04%	Dec 20, 2024
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $30	Strong Buy	Maintains	$30	+1,045.04%	Nov 21, 2024
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $30	Strong Buy	Maintains	$30	+1,045.04%	Nov 19, 2024
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $30	Strong Buy	Maintains	$30	+1,045.04%	Nov 12, 2024
Jason Kolbert EF Hutton	EF Hutton	Strong Buy Initiates $30	Strong Buy	Initiates	$30	+1,045.04%	Oct 23, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

16.27M

Increased by 2,515.59%

from 622.00K

Revenue Next Year

140.92M

Increased by 766.19%

from 16.27M

EPS This Year

-0.85

from -1.15

EPS Next Year

-0.69

from -0.85

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	2.20M	605.00K	934.00K	240.00K	622.00K	16.27M	140.92M	275.89M
Revenue Growth	-30.25%	-72.52%	54.38%	-74.30%	159.17%	2,515.59%	766.19%	95.78%
EPS	-0.43	-0.59	-0.89	-1.04	-1.15	-0.85	-0.69	-0.45
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	5	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028	2029
High	17.1M	179.3M	284.0M
Avg	16.3M	140.9M	275.9M
Low	15.3M	111.3M	265.1M

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028	2029
High	2,651.6%	1,002.1%	101.5%
Avg	2,515.6%	766.2%	95.8%
Low	2,357.9%	584.3%	88.1%

EPS Forecast

EPS	2024	2025	2026	2027	2028	2029
High	-0.70	-0.44	-0.28
Avg	-0.85	-0.69	-0.45
Low	-1.13	-1.00	-0.61

EPS Growth

EPS Growth	2024	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.